LEE, Mi Ock,이미옥,LEE, Bong Jin,이봉진,KIM, Eun Jin,김은진,KIM, Hyun Hwi,김현희
申请号：
KRKR2012/004327
公开号：
WO2013/015520A1
申请日:
2012.05.31
申请国别(地区):
KR
年份:
2013
代理人:
摘要：
Provided is a novel peptide for increasing the transcriptional activity of vascular endothelial growth factor (VEGF), which is important for wound treatment by means of activation of the HIF-1α gene, and a pharmaceutical composition including the peptide. The pharmaceutical composition of the present invention has the effects of wound treatment, skin tissue neogenesis, hair growth promotion, and the like.L'invention concerne un nouveau peptide pour l'amélioration de l'activité transcriptionnelle d'un facteur de croissance endothélial vasculaire (VEGF), qui est important pour le traitement de plaies, au moyen de l'activation du gène HIF-1α, et une composition pharmaceutique comprenant le peptide. La composition pharmaceutique de la présente invention présente les effets de traitement de plaies, de néogenèse de tissu cutané, la promotion de la croissance des poils, et similaires.본 발명은 HIF-1α 유전자를 활성화시켜 상처치료에 중요한 혈관내피세포성장인자(VEGF)의 전사 활성을 증가시키는 신규한 펩타이드 및 이를 포함하는 약학적 조성물 등을 제공한다. 상기 본 발명의 약학적 조성물은 상처치료, 피부 조직 재생과 발모 촉진 등의 효과를 가진다.
